首页> 外文期刊>Antimicrobial agents and chemotherapy. >First detection of trimethoprim resistance determinant dfrG in Streptococcus pyogenes clinical isolates in India
【24h】

First detection of trimethoprim resistance determinant dfrG in Streptococcus pyogenes clinical isolates in India

机译:在印度化脓性链球菌临床分离物中首次检测到甲氧苄啶抗性决定簇dfrG

获取原文
获取原文并翻译 | 示例
           

摘要

Streptococcus pyogenes is capable of causing a wide spectrum of diseases, ranging from throat and skin infection to life-threatening invasive diseases (2). The sequelae of streptococcal infections, such as acute rheumatic fever, represent a big health hazard (1). Recently, the emergence of invasive streptococcal diseases in India has been reported (5). Streptococcal emm types of the Indian subcontinent differ from those of other countries (7, 8). emml, which is one of the most prevalent invasive types of Western countries, is rare in India. Instead, another type, designated emml-2, is prevalent in India (8), and a subtype, emml-2.2, is associated with invasive disease (5).
机译:化脓性链球菌能够引起多种疾病,从咽喉和皮肤感染到威胁生命的浸润性疾病(2)。链球菌感染的后遗症,例如急性风湿热,对健康构成重大危害(1)。最近,有报道称印度出现了侵袭性链球菌疾病(5)。印度次大陆的链球菌emm类型不同于其他国家(7、8)。 emml是西方国家最普遍的侵入性类型之一,在印度很少见。相反,另一种称为emml-2的类型在印度很普遍(8),而亚型emml-2.2与侵袭性疾病有关(5)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号